Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Arcinova delighted to be finalists in OBN awards!

We have been shortlisted as an OBN awards finalist in the Best CRO category. We are delighted that our outstanding drug development services have been recognised by the OBN awards judges. The prestigious awards ceremony, which celebrates the exceptional work that has been achieved in the Life Sciences, will take place on the 7th November at the Oxford Examination Schools. Find out more here: https://obn-awards.com/award-finalists



 




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH